Skip to main content

Carisma Therapeutics Inc.

CARMDelisted Dec 15, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001485003

Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.

Q4 2024 vs. Q3 2024

How the institutions holding Carisma Therapeutics Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of CARM: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders37141+5
Shares5.21M1.25M5.62M+1.67M (+42.2%)
Value$5.11M$1.23M$2.35M−$1.53M (−39.3%)

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (14)

Institutions that held Carisma Therapeutics Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to CARM in Q4 2024
InstitutionSharesValue% of portfolio
Merck & Co., Inc.1,473,240$617.0K0.24%
AJU IB Investment Co., Ltd.718,332$300.8K0.29%
HRT Financial LP36,902$15.0K0.00%
Goldman Sachs Group Inc21,381$8.95K0.00%
LPL Financial LLC20,895$8.75K0.00%
Virtu Financial LLC17,327$7.00K0.00%
Dynamic Financial Group15,350$6.43K0.01%
Two Sigma Securities, LLC11,432$4.79K0.00%
Baader Bank INC11,804$4.42K0.00%
Union Bancaire Privee, UBP SA535$2270.00%
BNP Paribas Arbitrage, SA467$1960.00%
Carolina Wealth Advisors, LLC150$630.00%
Medallion Wealth Advisors, LLC100$310.00%
SBI Securities Co., Ltd.31$130.00%

Sold out (9)

Institutions that held Carisma Therapeutics Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of CARM in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
TPG GP A, LLC561,442$551.1K
Wexford Capital LP34,861$34.2K
Two Sigma Investments, LP34,141$33.5K
Qube Research & Technologies Ltd16,584$16.3K
Catalyst Funds Management Pty Ltd3,900$3.83K
FMR LLC736$722
Capital Performance Advisors LLP500$491
Nisa Investment Advisors, LLC161$158
McMahon Financial Advisors, LLC8$8

Not filed for Q4 2024 yet (1)

Institutions that held Carisma Therapeutics Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CARM in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Trustees of the University of Pennsylvania1,252,107$1.23M